MarketCapTrends
TCRT
Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare

Alaunos Therapeutics Inc. Shareholder Equity 2011–2025

Alaunos Therapeutics Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Alaunos Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 2.2M, a 4.36% increase year-over-year.
  • Alaunos Therapeutics Inc. shareholder equity for 2025 were 2.2M, a 4.36% increase from 2024.
  • Alaunos Therapeutics Inc. shareholder equity for 2024 were 2.1M, a 67.29% decrease from 2023.
  • Alaunos Therapeutics Inc. shareholder equity for 2023 were 6.3M, a 83.64% decrease from 2022.
  • Alaunos Therapeutics Inc. shareholder equity for 2022 were 38.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Alaunos Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$2
2024$2
2023$6
2022$39
2021$58
2020$124
2018$86
2017$-97
2016$-77
2012$48
2011$72
Alaunos Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$2
2024-12-31$2
2023-12-31$6
2022-12-31$39
2021-12-31$58
2020-12-31$124
2018-12-31$86
2017-12-31$-97
2016-12-31$-77
2012-12-31$48
2011-12-31$72

Alaunos Therapeutics Inc. Shareholder Equity — FAQ

Alaunos Therapeutics Inc. (TCRT) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TCRT's shareholder equity history?

The chart and table above show Alaunos Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.